Vitro Biopharma, Inc To Start Trading Tomorrow
Portfolio Pulse from Benzinga Insights
Vitro Biopharma, Inc (NASDAQ:VTRO) is set to start trading on the NASDAQ exchange under the ticker VTRO on September 13. The company is offering shares at an expected price between $5.00 and $6.00 per share with an insider lock-up period of 180 days ending on March 11, 2024. Vitro Biopharma is a biotechnology company targeting autoimmune diseases and inflammatory disorders.
September 12, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Vitro Biopharma is set to start trading on NASDAQ. The IPO price is expected to be between $5.00 and $6.00 per share. The company focuses on autoimmune diseases and inflammatory disorders.
The news of Vitro Biopharma's IPO is directly related to its stock. The IPO price and the company's focus area are key factors that investors will consider. This could potentially drive the stock price up in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100